175 related articles for article (PubMed ID: 37093665)
41. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
Shergill AK; Farraye FA
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
[TBL] [Abstract][Full Text] [Related]
42. Virtual chromoendoscopy with iSCAN as an alternative method to dye-spray chromoendoscopy for dysplasia detection in long-standing colonic inflammatory bowel disease: a case-control study.
López-Serrano A; Suárez MJ; Besó P; Algarra A; Latorre P; Barrachina MM; Paredes JM
Scand J Gastroenterol; 2021 Jul; 56(7):820-828. PubMed ID: 34043920
[TBL] [Abstract][Full Text] [Related]
43. DNA content abnormality frequently develops in the right/proximal colon in patients with primary sclerosing cholangitis and inflammatory bowel disease and is highly predictive of subsequent detection of dysplasia.
Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Histopathology; 2023 Jul; 83(1):116-125. PubMed ID: 37012656
[TBL] [Abstract][Full Text] [Related]
44. Evaluation and Detection of Dysplasia in IBD: the Role of Chromoendoscopy and Enhanced Imaging Techniques.
Buchner AM; Lichtenstein GR
Curr Treat Options Gastroenterol; 2016 Mar; 14(1):73-82. PubMed ID: 26831292
[TBL] [Abstract][Full Text] [Related]
45. Colorectal cancer surveillance with chromoendoscopy in inflammatory bowel disease: results from a real-life experience.
Rubín de Célix C; Chaparro M; Moreno JA; Santander C; Gisbert JP
Scand J Gastroenterol; 2021 Jul; 56(7):806-811. PubMed ID: 33905275
[TBL] [Abstract][Full Text] [Related]
46. Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease.
Shukla R; Salem M; Hou JK
World J Gastrointest Endosc; 2017 Aug; 9(8):359-367. PubMed ID: 28874956
[TBL] [Abstract][Full Text] [Related]
47. Concordance of Dye-Spraying Chromoendoscopy and Virtual Chromoendoscopy for Colonic Dysplasia Detection in Longstanding Inflammatory Bowel Disease.
Correia JPL; Ponte A; Proença L; Rodrigues A; Pinho R; Leite S; Fernandes C; Rodrigues J; Silva JC; Gomes C; Afecto E; Estevinho MM; Mesquita P; Freitas T
Turk J Gastroenterol; 2023 Nov; 34(11):1150-1155. PubMed ID: 37768309
[TBL] [Abstract][Full Text] [Related]
48. Systematic review with meta-analysis: Chromoendoscopy versus white light endoscopy in detection of dysplasia in patients with inflammatory bowel disease.
Wan J; Wang X; Yang ZP; Wu KC
J Dig Dis; 2019 Apr; 20(4):206-214. PubMed ID: 30756472
[TBL] [Abstract][Full Text] [Related]
49. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
[TBL] [Abstract][Full Text] [Related]
50. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
51. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Zhang R; Lauwers GY; Choi WT
J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
[TBL] [Abstract][Full Text] [Related]
52. Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.
Marion JF; Waye JD; Israel Y; Present DH; Suprun M; Bodian C; Harpaz N; Chapman M; Itzkowitz S; Abreu MT; Ullman TA; McBride RB; Aisenberg J; Mayer L;
Clin Gastroenterol Hepatol; 2016 May; 14(5):713-9. PubMed ID: 26656297
[TBL] [Abstract][Full Text] [Related]
53. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
[TBL] [Abstract][Full Text] [Related]
54. Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
Har-Noy O; Katz L; Avni T; Battat R; Bessissow T; Yung DE; Engel T; Koulaouzidis A; Eliakim R; Ben-Horin S; Kopylov U
Dig Dis Sci; 2017 Nov; 62(11):2982-2990. PubMed ID: 28965228
[TBL] [Abstract][Full Text] [Related]
55. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
Clarke WT; Feuerstein JD
World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
[TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
57. Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer.
Feuerstein JD; Rakowsky S; Sattler L; Yadav A; Foromera J; Grossberg L; Cheifetz AS
Gastrointest Endosc; 2019 Aug; 90(2):186-195.e1. PubMed ID: 31009609
[TBL] [Abstract][Full Text] [Related]
58. Performance measures in inflammatory bowel disease surveillance colonoscopy: Implementing changes to practice improves performance.
Smith SCL; Cannatelli R; Bazarova A; Sharma N; McCulloch A; Mak J; Shivaji UN; Iqbal T; Kane K; Ghosh S; Cooney R; Iacucci M
Dig Endosc; 2020 May; 32(4):592-599. PubMed ID: 31479541
[TBL] [Abstract][Full Text] [Related]
59. Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases.
Ten Hove JR; Mooiweer E; Dekker E; van der Meulen-de Jong AE; Offerhaus GJ; Ponsioen CY; Siersema PD; Oldenburg B
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):222-228.e2. PubMed ID: 27613257
[TBL] [Abstract][Full Text] [Related]
60. Knowledge and predictors of dysplasia surveillance performance in inflammatory bowel diseases in Australia.
Leong RW; Perry J; Campbell B; Koo J; Turner IB; Corte C; Fok IK
Gastrointest Endosc; 2015 Oct; 82(4):708-714.e4. PubMed ID: 26007222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
